Using the natural evolution of a rotavirus-specific human monoclonal antibody to predict the complex topography of a viral antigenic site

por McKinney, Brett A, Kallewaard, Nicole L, Crowe, James E, Meiler, Jens
Publicado 2007

Tackling influenza with broadly neutralizing antibodies

por Corti, Davide, Cameroni, Elisabetta, Guarino, Barbara, Kallewaard, Nicole L, Zhu, Qing, Lanzavecchia, Antonio
Publicado 2017

The Hemagglutinin A Stem Antibody MEDI8852 Prevents and Controls Disease and Limits Transmission of Pandemic Influenza Viruses

por Paules, Catharine I, Lakdawala, Seema, McAuliffe, Josephine M, Paskel, Myeisha, Vogel, Leatrice, Kallewaard, Nicole L, Zhu, Qing, Subbarao, Kanta
Publicado 2017

Influenza hemagglutinin membrane anchor

por Benton, Donald J., Nans, Andrea, Calder, Lesley J., Turner, Jack, Neu, Ursula, Lin, Yi Pu, Ketelaars, Esther, Kallewaard, Nicole L., Corti, Davide, Lanzavecchia, Antonio, Gamblin, Steven J., Rosenthal, Peter B., Skehel, John J.
Publicado 2018

The anti-SARS-CoV-2 monoclonal antibody, bamlanivimab, minimally impacts the endogenous immune response to COVID-19 vaccination

por Benschop, Robert J., Tuttle, Jay L., Zhang, Lin, Poorbaugh, Josh, Kallewaard, Nicole L., Vaillancourt, Peter, Crisp, Melissa, Trinh, Thi Ngoc Vy, Freitas, Joshua J., Beasley, Stephanie, Daniels, Montanea, Haustrup, Natalie, Higgs, Richard E., Nirula, Ajay, Cohen, Myron S., Marovich, Mary
Publicado 2022

Pharmacokinetics, Efficacy, and Safety of a SARS-CoV-2 Antibody Treatment in Pediatric Participants: An Open-Label Addendum of a Placebo-Controlled, Randomized Phase 2/3 Trial

por Upadhyaya, Himanshu P., Chien, Jenny Y., Long, Amanda J., Bohm, Martin S., Kallewaard, Nicole L., Macpherson, Lisa F., Patel, Dipak R., Hufford, Matthew M., Krull, Constance J., Ang, Jocelyn Y., Chen, Peter, Muller, William J., Potts, Jeffrey A., Quinn, Timothy, Williams, Mark
Publicado 2023

Endogenous Antibody Responses to SARS-CoV-2 in Patients With Mild or Moderate COVID-19 Who Received Bamlanivimab Alone or Bamlanivimab and Etesevimab Together

por Zhang, Lin, Poorbaugh, Josh, Dougan, Michael, Chen, Peter, Gottlieb, Robert L., Huhn, Gregory, Beasley, Stephanie, Daniels, Montanea, Ngoc Vy Trinh, Thi, Crisp, Melissa, Freitas, Joshua Joaquin, Vaillancourt, Peter, Patel, Dipak R., Nirula, Ajay, Kallewaard, Nicole L., Higgs, Richard E., Benschop, Robert J.
Publicado 2021

DMAb inoculation of synthetic cross reactive antibodies protects against lethal influenza A and B infections

por Elliott, Sarah T. C., Kallewaard, Nicole L., Benjamin, Ebony, Wachter-Rosati, Leslie, McAuliffe, Josephine M., Patel, Ami, Smith, Trevor R. F., Schultheis, Katherine, Park, Daniel H., Flingai, Seleeke, Wise, Megan C., Mendoza, Janess, Ramos, Stephanie, Broderick, Kate E., Yan, Jian, Humeau, Laurent M., Sardesai, Niranjan Y., Muthumani, Kar, Zhu, Qing, Weiner, David B.
Publicado 2017

Developability profiling of a panel of Fc engineered SARS-CoV-2 neutralizing antibodies

por Dippel, Andrew, Gallegos, Austin, Aleti, Vineela, Barnes, Arnita, Chen, Xiaoru, Christian, Elizabeth, Delmar, Jared, Du, Qun, Esfandiary, Reza, Farmer, Erika, Garcia, Andrew, Li, Qing, Lin, Jia, Liu, Weiyi, Machiesky, LeeAnn, Mody, Neil, Parupudi, Arun, Prophet, Meagan, Rickert, Keith, Rosenthal, Kim, Ren, Song, Shandilya, Harini, Varkey, Reena, Wons, Kevin, Wu, Yuling, Loo, Yueh-Ming, Esser, Mark T., Kallewaard, Nicole L., Rajan, Sarav, Damschroder, Melissa, Xu, Weichen, Kaplan, Gilad
Publicado 2022

Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes

por Kallewaard, Nicole L., Corti, Davide, Collins, Patrick J., Neu, Ursula, McAuliffe, Josephine M., Benjamin, Ebony, Wachter-Rosati, Leslie, Palmer-Hill, Frances J., Yuan, Andy Q., Walker, Philip A., Vorlaender, Matthias K., Bianchi, Siro, Guarino, Barbara, De Marco, Anna, Vanzetta, Fabrizia, Agatic, Gloria, Foglierini, Mathilde, Pinna, Debora, Fernandez-Rodriguez, Blanca, Fruehwirth, Alexander, Silacci, Chiara, Ogrodowicz, Roksana W., Martin, Stephen R., Sallusto, Federica, Suzich, JoAnn A., Lanzavecchia, Antonio, Zhu, Qing, Gamblin, Steven J., Skehel, John J.
Publicado 2016

Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19

por Dougan, Michael, Nirula, Ajay, Azizad, Masoud, Mocherla, Bharat, Gottlieb, Robert L., Chen, Peter, Hebert, Corey, Perry, Russell, Boscia, Joseph, Heller, Barry, Morris, Jason, Crystal, Chad, Igbinadolor, Awawu, Huhn, Gregory, Cardona, Jose, Shawa, Imad, Kumar, Princy, Adams, Andrew C., Van Naarden, Jacob, Custer, Kenneth L., Durante, Michael, Oakley, Gerard, Schade, Andrew E., Holzer, Timothy R., Ebert, Philip J., Higgs, Richard E., Kallewaard, Nicole L., Sabo, Janelle, Patel, Dipak R., Dabora, Matan C., Klekotka, Paul, Shen, Lei, Skovronsky, Daniel M.
Publicado 2021

The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in non-human primates and has an extended half-life in humans

por Loo, Yueh-Ming, McTamney, Patrick M., Arends, Rosalinda H., Abram, Michael E., Aksyuk, Anastasia A., Diallo, Seme, Flores, Daniel J., Kelly, Elizabeth J., Ren, Kuishu, Roque, Richard, Rosenthal, Kim, Streicher, Katie, Tuffy, Kevin M., Bond, Nicholas J., Cornwell, Owen, Bouquet, Jerome, Cheng, Lily I., Dunyak, James, Huang, Yue, Rosenbaum, Anton I., Reddy, Venkatesh Pilla, Andersen, Hanne, Carnahan, Robert H., Crowe, James E., Kuehne, Ana I., Herbert, Andrew S., Dye, John M., Bright, Helen, Kallewaard, Nicole L., Pangalos, Menelas N., Esser, Mark T.
Publicado 2022

Potently neutralizing and protective human antibodies against SARS-CoV-2

por Zost, Seth J., Gilchuk, Pavlo, Case, James Brett, Binshtein, Elad, Chen, Rita E., Nkolola, Joseph P., Schäfer, Alexandra, Reidy, Joseph X., Trivette, Andrew, Nargi, Rachel S., Sutton, Rachel E., Suryadevara, Naveenchandra, Martinez, David R., Williamson, Lauren E., Chen, Elaine C., Jones, Taylor, Day, Samuel, Myers, Luke, Hassan, Ahmed O., Kafai, Natasha M., Winkler, Emma S., Fox, Julie M., Shrihari, Swathi, Mueller, Benjamin K., Meiler, Jens, Chandrashekar, Abishek, Mercado, Noe B., Steinhardt, James J., Ren, Kuishu, Loo, Yueh-Ming, Kallewaard, Nicole L., McCune, Broc T., Keeler, Shamus P., Holtzman, Michael J., Barouch, Dan H., Gralinski, Lisa E., Baric, Ralph S., Thackray, Larissa B., Diamond, Michael S., Carnahan, Robert H., Crowe, James E.
Publicado 2020

LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

por Westendorf, Kathryn, Žentelis, Stefanie, Wang, Lingshu, Foster, Denisa, Vaillancourt, Peter, Wiggin, Matthew, Lovett, Erica, van der Lee, Robin, Hendle, Jörg, Pustilnik, Anna, Sauder, J. Michael, Kraft, Lucas, Hwang, Yuri, Siegel, Robert W., Chen, Jinbiao, Heinz, Beverly A., Higgs, Richard E., Kallewaard, Nicole L., Jepson, Kevin, Goya, Rodrigo, Smith, Maia A., Collins, David W., Pellacani, Davide, Xiang, Ping, de Puyraimond, Valentine, Ricicova, Marketa, Devorkin, Lindsay, Pritchard, Caitlin, O’Neill, Aoise, Dalal, Kush, Panwar, Pankaj, Dhupar, Harveer, Garces, Fabian A., Cohen, Courtney A., Dye, John M., Huie, Kathleen E., Badger, Catherine V., Kobasa, Darwyn, Audet, Jonathan, Freitas, Joshua J., Hassanali, Saleema, Hughes, Ina, Munoz, Luis, Palma, Holly C., Ramamurthy, Bharathi, Cross, Robert W., Geisbert, Thomas W., Menachery, Vineet, Lokugamage, Kumari, Borisevich, Viktoriya, Lanz, Iliana, Anderson, Lisa, Sipahimalani, Payal, Corbett, Kizzmekia S., Yang, Eun Sung, Zhang, Yi, Shi, Wei, Zhou, Tongqing, Choe, Misook, Misasi, John, Kwong, Peter D., Sullivan, Nancy J., Graham, Barney S., Fernandez, Tara L., Hansen, Carl L., Falconer, Ester, Mascola, John R., Jones, Bryan E., Barnhart, Bryan C.
Publicado 2022